Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb Infections

NCT04919954 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT04919954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04919954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb Infections
Lead sponsor
Hartford Hospital
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2021
Completion date
December 23, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

absssi, diabetes, healthy volunteers, wound infection